MedPath

Suprane

These highlights do not include all the information needed to use Suprane (desflurane, USP) safely and effectively. See full prescribing information for Suprane (desflurane, USP).Suprane (desflurane, USP) Volatile Liquid for InhalationInitial U.S. Approval:  1992

Approved
Approval ID

a3e4c8e5-bff0-4a8f-8401-e9866c846ee2

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 16, 2023

Manufacturers
FDA

Henry Schein, Inc.

DUNS: 012430880

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Desflurane

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0404-9961
Application NumberNDA020118
Product Classification
M
Marketing Category
C73594
G
Generic Name
Desflurane
Product Specifications
Route of AdministrationRESPIRATORY (INHALATION)
Effective DateNovember 16, 2023
FDA Product Classification

INGREDIENTS (1)

DesfluraneActive
Quantity: 240 mL in 240 mL
Code: CRS35BZ94Q
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Suprane - FDA Drug Approval Details